Role of Ethanolamine Utilization Genes in Host Colonization during Urinary Tract Infection

ABSTRACT Urinary tract infection (UTI) is the second most common infection in humans, making it a global health priority. Nearly half of all women will experience a symptomatic UTI, with uropathogenic Escherichia coli (UPEC) being the major causative agent of the infection. Although there has been extensive research on UPEC virulence determinants, the importance of host-specific metabolism remains understudied. We report here that UPEC upregulates the expression of ethanolamine utilization genes during uncomplicated UTIs in humans. We further show that UPEC ethanolamine metabolism is required for effective bladder colonization in the mouse model of ascending UTI and is dispensable for bladder colonization in an immunocompromised mouse model of UTI. We demonstrate that although ethanolamine metabolism mutants do not show increased susceptibility to antimicrobial responses of neutrophils, this metabolic pathway is important for surviving the innate immune system during UTI. This study reveals a novel aspect of UPEC metabolism in the host and provides evidence for an underappreciated link between bacterial metabolism and the host immune response.

[1]  D. Hunstad,et al.  Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli , 2016, Infection and Immunity.

[2]  M. M. Kendall,et al.  Location, location, location. Salmonella senses ethanolamine to gauge distinct host environments and coordinate gene expression , 2016, Microbial cell.

[3]  Patrick D. Olson,et al.  Subversion of Host Innate Immunity by Uropathogenic Escherichia coli , 2016, Pathogens.

[4]  Mazhar Adli,et al.  Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection , 2015, PLoS pathogens.

[5]  Y. Miao,et al.  The nature of immune responses to urinary tract infections , 2015, Nature Reviews Immunology.

[6]  H. Mobley,et al.  Virulence and Fitness Determinants of Uropathogenic Escherichia coli , 2015, Microbiology spectrum.

[7]  T. Bobik,et al.  In Salmonella enterica, Ethanolamine Utilization Is Repressed by 1,2-Propanediol To Prevent Detrimental Mixing of Components of Two Different Bacterial Microcompartments , 2015, Journal of bacteriology.

[8]  S. Hultgren,et al.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options , 2015, Nature Reviews Microbiology.

[9]  C. Alteri,et al.  Preferential Use of Central Metabolism In Vivo Reveals a Nutritional Basis for Polymicrobial Infection , 2015, PLoS pathogens.

[10]  C. Alteri,et al.  Metabolism and Fitness of Urinary Tract Pathogens , 2015, Microbiology spectrum.

[11]  D. Rasko,et al.  Host-specific induction of Escherichia coli fitness genes during human urinary tract infection , 2014, Proceedings of the National Academy of Sciences.

[12]  Pascale Cossart,et al.  Sequestration of a two-component response regulator by a riboswitch-regulated noncoding RNA , 2014, Science.

[13]  M. M. Kendall,et al.  Ethanolamine and Choline Promote Expression of Putative and Characterized Fimbriae in Enterohemorrhagic Escherichia coli O157:H7 , 2013, Infection and Immunity.

[14]  M. M. Kendall,et al.  EutR Is a Direct Regulator of Genes That Contribute to Metabolism and Virulence in Enterohemorrhagic Escherichia coli O157:H7 , 2013, Journal of bacteriology.

[15]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[16]  D. Hunstad,et al.  YbcL of Uropathogenic Escherichia coli Suppresses Transepithelial Neutrophil Migration , 2012, Infection and Immunity.

[17]  V. Sperandio,et al.  Ethanolamine Controls Expression of Genes Encoding Components Involved in Interkingdom Signaling and Virulence in Enterohemorrhagic Escherichia coli O157:H7 , 2012, mBio.

[18]  A. Zychlinsky,et al.  Neutrophil function: from mechanisms to disease. , 2012, Annual review of immunology.

[19]  J. Roth,et al.  Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota , 2011, Proceedings of the National Academy of Sciences.

[20]  J. Harel,et al.  Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content. , 2011, Environmental microbiology.

[21]  Betsy Foxman,et al.  The epidemiology of urinary tract infection , 2010, Nature Reviews Urology.

[22]  Jonathan Crabtree,et al.  Ergatis: a web interface and scalable software system for bioinformatics workflows , 2010, Bioinform..

[23]  D. Garsin.  Ethanolamine utilization in bacterial pathogens: roles and regulation , 2010, Nature Reviews Microbiology.

[24]  H. Mobley,et al.  Waging War against Uropathogenic Escherichia coli: Winning Back the Urinary Tract , 2009, Infection and Immunity.

[25]  A. Mushegian,et al.  Comparative Genomics of Ethanolamine Utilization , 2009, Journal of bacteriology.

[26]  H. Mobley,et al.  Uropathogenic Escherichia coli Suppresses the Host Inflammatory Response via Pathogenicity Island Genes sisA and sisB , 2009, Infection and Immunity.

[27]  C. Alteri,et al.  Fitness of Escherichia coli during Urinary Tract Infection Requires Gluconeogenesis and the TCA Cycle , 2009, PLoS pathogens.

[28]  F. Tacke,et al.  CCR2 Mediates Homeostatic and Inflammatory Release of Gr1high Monocytes from the Bone Marrow, but Is Dispensable for Bladder Infiltration in Bacterial Urinary Tract Infection1 , 2008, The Journal of Immunology.

[29]  Michael D. Connolly,et al.  Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice , 2008, Journal of leukocyte biology.

[30]  Harry L. T. Mobley,et al.  Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract , 2007, Proceedings of the National Academy of Sciences.

[31]  A. Schaeffer,et al.  Modulation of Host Innate Immune Response in the Bladder by Uropathogenic Escherichia coli , 2007, Infection and Immunity.

[32]  S. Hultgren,et al.  Filamentation by Escherichia coli subverts innate defenses during urinary tract infection , 2006, Proceedings of the National Academy of Sciences.

[33]  T. Hökfelt,et al.  The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection , 2006, Nature Medicine.

[34]  W. Goebel,et al.  Identification of Listeria monocytogenes Genes Contributing to Intracellular Replication by Expression Profiling and Mutant Screening , 2006, Journal of bacteriology.

[35]  S. Hultgren,et al.  Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.

[36]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Jarvis,et al.  Isogenic P‐fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of α Gal(1–4)β Gal binding in virulence of a wild‐type strain , 1993 .

[38]  K. Jarvis,et al.  Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. , 1993, Molecular microbiology.

[39]  D. Longo,et al.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. , 1991, Journal of immunology.

[40]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[41]  H. Mobley,et al.  Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. , 1987, The Journal of urology.

[42]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.